Implement Safety Responsibility, Promote Safety Development, Make Safety Accidents "Can't Make" Company's Safety Production Month Activities Launch New Patterns
Release time:
2021-06-01
News from our newspaper Group Company recently issued the "Overall Safety Month Activity Plan for 2021 " to make arrangements for organizing a series of safety production activities in 6# June. Compared with the past, this safety month activity has added a new content called "I'll teach you a lesson", which is intended to allow employees to analyze from the people and things around them, so as to promote mutual communication and enhance awareness of prevention., The purpose of making safety accidents "impossible.
This year 6# November is the 20th "safe production month" in the country, with the theme of "implementing safety responsibilities and promoting safe development"; 2021 is also the first year of the company's three-year action plan for on-site governance. Therefore, the guiding ideology of this year's safety month is as follows, combine the three-year on-site governance action plan that the company is promoting, the theme of safety production month activities, and the guiding ideology of safety work that makes safety accidents "impossible", and use safety month activities as the carrier to carry out a series of safety activities to promote the company's safety The production situation continues to be stable, and a safe factory and a happy factory will be built.
Notice requires that all subordinate units of the company shall hang or post "safe production month" publicity materials on publicity boards, office places and production workshops (places), and publish "safe production month" activity information in various forms such asQQ and WeChat to create a strong safety atmosphere. Centrally organize and watch the safety production month warning education propaganda film and other warning education materials, deeply learn the lessons of accidents and improve the awareness and ability of prevention; Take the workshop or workshop section as a unit, make a comprehensive analysis of the risks in process, equipment and operation, and carry out the work of eliminating on-site defects and improving the environment in combination with the on-site treatment and rectification plan; Carry out emergency plan drills, especially the operational and practical initial emergency disposal drills of the front-line staff of the workshop team, strengthen the awareness of standards and specifications, and improve the emergency disposal capability; carry out comprehensive production safety inspection.
Compared with the past, this safety month activity has a new project called "I will give you a lesson", that is, around the theme of making safety accidents "impossible", through the analysis of safety cases around you, and in the way of "I will give you a lesson", the exchange and training activities of safety management concept and safety knowledge are carried out, to achieve the purpose of mutual promotion and common improvement. The content of the course is mainly based on the sharing of safety concepts and management experience, case analysis of safety accidents inside and outside the enterprise, and the inspection and elimination of potential safety hazards. Each unit determines the teaching personnel by the combination of designation and registration. In addition to teaching in the unit, it will also be recommended to the group company for "big lessons". According to the quality and effect of teaching, teaching staff will also be given certain rewards.(Reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page